Latest pulmonary fibrosis Stories
New data will be reported to FDA at patient-focused drug development meeting on 9/26; insights will help future PFF programs and services CHICAGO, Aug.
MORRISTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Moerae Matrix, Inc.
Patients, caregivers and health care professionals share stories; offer awareness, hope and inspiration CHICAGO, July 23, 2014 /PRNewswire-USNewswire/ -- Twenty of the Pulmonary Fibrosis
Nintedanib and Pirfenidone Received Breakthrough Therapy Designation by the U.S.
For U.S. Media Only RIDGEFIELD, Conn., July 16, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S.
RIDGEFIELD, Conn., July 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
RIDGEFIELD, Conn., June 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the company has initiated an open-label, U.S.
CHICAGO, June 10, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced a key partnership with Biogen Idec in support of the PFF Patient Registry.
Scientists at the Helmholtz Zentrum München (HMGU) working in cooperation with the Ludwig-Maximilians-Universität Hospital and the Technische Universität München (TUM) have for the first time tested X-ray dark-field radiography on a living organism to diagnose lung disease.
Results from Boehringer Ingelheim, InterMune and IPFnet clinical trials discussed CHICAGO, May 18, 2014 /PRNewswire-USNewswire/ -- WHO: The Pulmonary Fibrosis
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.